Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03701074 · ClinicalTrials.gov registry record · Phase 2
Randomized Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus
A Phase 2 study, sponsored by University of South Alabama.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT03701074: Clinical Trial Phase 2 study, sponsored by University of South Alabama.
NCT03701074 is a Phase 2 study that was terminated before completion, run by University of South Alabama. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03701074, a Phase 2 study, was terminated before completion, sponsored by University of South Alabama.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of the present study is to determine whether treatment of hemodynamically significant patent ductus arteriosus with a combined therapy of intravenous Ibuprofen and oral acetaminophen has higher success rate in closing the ductus arteriosus than a standard treatment strategy of using intravenous ibuprofen alone among preterm infants.
Interventions
- DRUG Ibuprofen and acetaminophen
- DRUG Ibuprofen and placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-12-15 |
| Est. Completion | 2020-12-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03701074
The ClinicalTrials.gov registry entry for NCT03701074 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Alabama, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ibuprofen and acetaminophen is the first listed.
NCT03701074 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03701074 about?
NCT03701074 is a clinical study titled "Randomized Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus". The purpose of the present study is to determine whether treatment of hemodynamically significant patent ductus arteriosus with a combined therapy of intravenous Ibuprofen and oral acetaminophen has higher success rate in closing the ductus arteriosus than a standard treatment strategy of using intr...
What is the current status of trial NCT03701074?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2018-12-15. Estimated completion is 2020-12-02.
What interventions are being tested in trial NCT03701074?
The interventions under investigation include: Ibuprofen and acetaminophen (DRUG), Ibuprofen and placebo (DRUG).
Who is sponsoring clinical trial NCT03701074?
This trial is sponsored by University of South Alabama, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.